GlassScriptPhysician profile
Elissa H Kravis
NPI 1194200238
$677.18
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2023: $176 · 2024: $23.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $174.77 | 2021-2023 | Menopur |
| Ucb, INC. | $115.92 | 2021 | |
| Sk Life Science, INC. | $87.34 | 2021 | |
| Amgen INC. | $65.20 | 2021 | |
| Adamas Pharmaceuticals, INC. | $43.46 | 2021 | |
| Arbor Pharmaceuticals, INC. | $37.42 | 2021 | |
| Lundbeck LLC | $30.38 | 2021 | |
| Abbvie INC. | $24.55 | 2021 | |
| Emd Serono, INC. | $23.01 | 2024 | |
| Boston Scientific Corporation | $19.16 | 2023 | Watchman Access System |
| Collegium Pharmaceutical, INC. | $15.04 | 2021 | |
| Ge Healthcare | $14.62 | 2021 | |
| Neurocrine Biosciences, INC. | $13.55 | 2021 | |
| Mdd US Operations, LLC | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elissa Kravis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.